Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography: Preliminary results of an animal study original investigation

Investigative Radiology

Volumn 33, Issue 9, 1998, Pages 637-643

  Knollmann, Friedrich D ^a,c   Böck, Johannes C ^a   Rautenberg, Kerstin ^a   Beier, Jürgen ^a   Ebert, Wolfgang ^b   Felix, Roland ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BAYER PHARMA AG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Contrast agents; Iron oxides; Magnetic resonance angiography; Particle size; Portal vein

Indexed keywords

SHU 555C; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PARTICLE SIZE; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL;

EID: 0342699623     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199809000-00019     Document Type: Article

References (14)

1. Knollmann FD, Böck JC, Teltenkötter S, et al. Evaluation of portal MR angiography using superparamagnetic iron oxide. J Magn Res Imag 1997;7:191-196.
2. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxides: Preliminary studies in whole-blood phantom and in animals. AJR 1994;162:209-211.
3. Bulte JWM, Vymazal J, Brooks RA, Pierpaoli C, Frank JA. Frequency dependence of MR relaxation times: II. Iron oxides. J Magn Reson Imaging 1993;3:641-648.
4. Brown DG, Riederer SJ. Contrast-to-noise ratios in maximum intensity projection images. Magn Reson Med 1992;23:130-137.
5. Pouliquen D, Perroud H, Jallet P, Le Jeune JJ. Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI. Magn Reson Med 1993;24:75-84.
6. Canet E, Revel D, Forrat R et al. Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond Tl-weighted MRI. Magn Reson Imaging 1993;11:1139-1145.
7. Shirkoda A, Konez O, Shetty AN, Bis KG, Ellwood RA, Kirsch MJ. Mesenteric circulation: Three-dimensional MR angiography with a gadolinium-enhanced multiecho gradient-echo sequence. Radiology 1997;202:257-261.
8. Hughes LA, Hartnell GG, Finn JP, et al. Time-of-flight MR angiography of the portal venous system: Value compared with other imaging procedures. AJR 1996;166:375-378.
9. Silverman JM, Podesta L, Villamil F, et al. Portal vein patency in candidates for liver transplantation: MR angiographic analysis. Radiology 1995;197:147-152.
10. Lee JPK. Variation in portal and hepatic venous anatomy as shown by magnetic resonance imaging: Implications for transjugular intrahepatic portosystemic shunt. Clin Radiol 1995;50:108-110.
11. McFarland E, Kaufman JA, Saini S, et al. Preoperative staging of cancer of the pancreas: Value of MR angiography versus conventional angiography in detecting portal venous invasion. AJR 1996; 166:37-43.
12. Chambon C, Clement O, LeBlanche A, Schouman-Clays E, Frija G. Superparamagnetic iron oxides as positive MR contrast agents: In vitro and in vivo evidence. Magn Reson Imag 1993;11:509-519.
13. Yamashita Y, Mitsuzaki K, Miyazaki T, et al. Gadolinium-enhanced breath-hold three-dimensional MR angiography of the portal vein: Value of magnetization-prepared rapid acquisition gradient-echo sequence. Radiology 1996;201:283-288.
14. Leung DA, McKinnon GC, Davis CP, Pfammatter T, Krestin G, Debatin JF. Breath-hold, contrast-enhanced, three-dimensional MR angiography. Radiology 1996;201:569-571.